SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-115408
Filing Date
2022-11-07
Accepted
2022-11-07 16:05:45
Documents
16
Period of Report
2022-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2229816d1_8k.htm   iXBRL 8-K 32494
2 EXHIBIT 1.1 tm2229816d1_ex1-1.htm EX-1.1 218985
3 EXHIBIT 5.1 tm2229816d1_ex5-1.htm EX-5.1 9722
7 GRAPHIC tm2229816d1_ex5-1img001.jpg GRAPHIC 5106
8 GRAPHIC tm2229816d1_ex5-1img002.jpg GRAPHIC 26206
  Complete submission text file 0001104659-22-115408.txt   533818

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrsn-20221107.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrsn-20221107_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrsn-20221107_pre.xml EX-101.PRE 22593
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2229816d1_8k_htm.xml XML 3483
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 221365399
SIC: 2834 Pharmaceutical Preparations